ramosetron
Selected indexed studies
- Effects of Ramosetron on Nausea and Vomiting Following Spinal Surgery: A Meta-Analysis. (Curr Ther Res Clin Exp, 2022) [PMID:35464291]
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. (Cochrane Database Syst Rev, 2020) [PMID:33075160]
- Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials. (BMC Gastroenterol, 2018) [PMID:29310568]
_Worker-drafted node — pending editorial review._
Connections
ramosetron is a side effect of
Sources
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. (2020) pubmed
- Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. (2022) pubmed
- Effects of Ramosetron on Nausea and Vomiting Following Spinal Surgery: A Meta-Analysis. (2022) pubmed
- Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials. (2018) pubmed
- Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting. (2002) pubmed
- Comparison of ramosetron and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials. (2019) pubmed
- Low anterior resection syndrome. (2023) pubmed
- Pharmacological profile of ramosetron, a novel therapeutic agent for IBS. (2007) pubmed
- Palonosetron and Ramosetron Compared for Effectiveness in Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis. (2016) pubmed
- Comparison of the Effectiveness of Palonosetron and Ramosetron in Preventing Postoperative Nausea and Vomiting: Updated Systematic Review and Meta-Analysis with Trial Sequential Analysis. (2022) pubmed